Reference
- Montague K, Barbada JH, Belker AM, Levine LA, Nadig PVV, Roehrborn CG, Sharlip ID, Bennett AH (1996). Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J. Urol., 156, 2007–2011.
- van Zwieten PA, Chalmers JP (1994). Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc. Drugs Ther., 6,787–799.
- Zorgniotti AW (1994). Eperience with buccal phentolamine mesylate for impotence. Int. J. Impotence Res., 6,37–41.
- Kurt U, Ozkardes H, Altug U, Germianoglu C, Gurdal M, Erol D (1994). The efficacy of antiserotoninergic agents in the treatment of erectile dysfunction. J. Urol., 152,407–409.
- Lance R, Albo M, Costabile R, Streers W (1995). Oral Trazodone as empirical therapy for erectile dysfunction: a retrospective review. Urology, 46, 117–120.
- Heaton J, Morales A, Adams M, Johnston B, El-Rashidy R (1995). Recovery of erectile function by the oral administration of apomorphine. Urology, 45, 200–205.
- Zorgniotti AVV, Lizza EF (1994). Effect of large doses of the nitric oxide precursor, Larginine, on erectile dysfunction. Int. J. Impotence Res., 6,33–36.
- Zusman RM, Morales A, Glasser DB, Osterloh IH (1999). Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol., 83(5A), 35C–44C.
- Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH (1998). Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int. J. Impotence Res., 10, 69–73; discussion 73–4.
- Kloner RA, Jarrow JP (1999). Erectile dysfunction and sildenafil citrate and cardiologists [editorial]. Am. J. Cardiol., 83, 576–582, A7.
- Conti CR, Pepine CJ, Sweeney M (1999). Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Am. J. Cardiol., Mar, 83 (5A), 29C–34C.